# Fermented Soy Cholesterol Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/fermented-soy-cholesterol-meta-analysis-evidence-review
Category: evidence-review
Summary: Fermented Soy Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are
Last reviewed: 2026-07-09
Reviewed by: Migaku Evidence Review
# Fermented Soy Cholesterol Meta-analysis: What the Evidence Says

## Quick Answer

Fermented Soy Cholesterol Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Fermented foods consumption, all-cause, and cause-specific mortality: a meta-analysis of prospective cohort studies | systematic review | 1 | 2026-02-26 | 10.3389/fnut.2026.1714437 |
| Soy and the gut microbiome: a bi-directional relationship shaping nutrition and health | narrative review | 3 | 2026-02-12 | 10.1007/s00394-026-03900-4 |

## What The Sources Report

- Diet quality, including degree of food processing and nutritional composition, is an important determinant of morbidity and mortality risk. [Matalas Antonia (2026); evidence level 1]
- Beyond improving food preservation and safety, it generates bioactive compounds and microbial metabolites that may exert functional effects on health, thereby linking fermented foods with long-term disease prevention and mortality risk. [Matalas Antonia (2026); evidence level 1]
- Where a mechanism has not been established but the disease-microbiome association is reproducible, as for many non-communicable multi-factorial lifestyle diseases, a pragmatic approach is to treat the microbiota as an environmental modifier of disease risk. [Nolan Laura (2026); evidence level 3]
- Emerging evidence suggests that prebiotics, gut microbes, and their products may mitigate the effects of mycotoxins in food, emphasizing the complexity of these interactions. [Nolan Laura (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For fermented soy cholesterol meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Matalas Antonia (2026). Fermented foods consumption, all-cause, and cause-specific mortality: a meta-analysis of prospective cohort studies. DOI: 10.3389/fnut.2026.1714437. PMCID: PMC12979560. PMID: 41835372. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12979560/
- Nolan Laura (2026). Soy and the gut microbiome: a bi-directional relationship shaping nutrition and health. DOI: 10.1007/s00394-026-03900-4. PMCID: PMC12901295. PMID: 41677879. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12901295/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.